Rethinking Alzheimer’s research, beyond amyloid deposition, via new funding models

How a new approach to fund­ing Alzheimer’s research could pay off (MIT News): “More than 5 mil­lion Amer­i­cans suf­fer from Alzheimer’s dis­ease, the afflic­tion that erodes mem­o­ry and oth­er men­tal capac­i­ties, but no drugs tar­get­ing the dis­ease have been approved by the U.S. Food and Drug Admin­is­tra­tion since 2003…Lo and three co-authors propose 

Read More